Strata Critical Medical Inc.

06/03/2026 | Press release | Distributed by Public on 06/03/2026 14:25

Proxy Results (Form 8-K)

Item 5.07 - Submission of Matters to a Vote of Security Holders.
On May 28, 2026, Strata Critical Medical, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). The proposals are described in the Company's definitive proxy statement for the Annual Meeting, as filed with the Securities and Exchange Commission on April 14, 2026. The final results for the votes regarding each proposal are set forth below.
1.The Company's stockholders elected the two (2) Class II directors listed below to the Board of Directors of the Company to hold office until the 2029 annual meeting of stockholders and until their respective successors have been duly elected and qualified. The votes regarding this proposal were as follows:
For
Withhold
Broker Non-Votes
William A. Heyburn
46,050,902
505,421
12,687,496
Andrew Lauck
39,525,159
7,031,164
12,687,496
2.The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes regarding this proposal were as follows:
For
Against
Abstain
58,946,832
65,815
231,172
3.The Company's stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote). The votes regarding this proposal were as follows:
For
Against
Abstain
Broker Non-Votes
38,497,962
8,022,682
35,679
12,687,496
Strata Critical Medical Inc. published this content on June 03, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 03, 2026 at 20:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]